Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Amgen
(NQ:
AMGN
)
305.02
-0.67 (-0.22%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Amgen
< Previous
1
2
...
31
32
33
34
35
36
37
38
Next >
7 Drug Stocks to Buy Now While They’re Still on Sale
November 30, 2021
Covid-19 stocks soared to unsustainable highs as investors ignored drug stocks with a deep pipeline of products for the decade ahead.
Via
InvestorPlace
Topics
Supply Chain
Exposures
COVID-19
Supply Chain
Amgen: For Growth And Income Investors
November 29, 2021
Amgen focuses on six therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology, and inflammation.
Via
Talk Markets
Price Over Earnings Overview: Amgen
November 29, 2021
In the current market session, Amgen Inc. (NASDAQ:AMGN) is trading at $202.59, after a 0.75% gain. However, over the past month, the stock fell by 5.41%, and in the...
Via
Benzinga
Bristol Myers' Deucravacitinib Under FDA Review For Plaque Psoriasis
November 29, 2021
The FDA has accepted for review Bristol Myers Squibb & Co's (NYSE: BMY) deucravacitinib for the treatment of adults with moderate to severe plaque psoriasis...
Via
Benzinga
Exposures
Product Safety
3 Best Biopharma Stocks to Buy During This Industrywide Fire Sale
November 28, 2021
Affimed, Amgen, and Bristol Myers Squibb are too cheap to ignore right now.
Via
The Motley Fool
Exposures
COVID-19
Analyst Ratings For Amgen
November 19, 2021
Within the last quarter, Amgen (NASDAQ:AMGN) has observed the following ana...
Via
Benzinga
Where Amgen Stands With Analysts
November 03, 2021
Within the last quarter, Amgen (NASDAQ:AMGN) has observed the following ana...
Via
Benzinga
Should You Buy This Giant Biotech Stock?
November 26, 2021
Amgen beat analysts' earnings expectations in the third quarter, and its balance sheet remains admirable.
Via
The Motley Fool
10 Biggest Price Target Changes For Monday
November 22, 2021
MKM Partners cut Activision Blizzard, Inc. (NASDAQ:A...
Via
Benzinga
2 Dividend Stocks to Buy Right Now
November 19, 2021
These two drugmakers have a solid track record.
Via
The Motley Fool
3 Pharma Stocks That Could Make You Richer in November (and Beyond)
November 12, 2021
Two of them have already been big winners for investors this year.
Via
The Motley Fool
Here Are the Highlights From Amgen's Q3 Results
November 11, 2021
The big biotech reported only modest sales growth.
Via
The Motley Fool
CNBC's Final Trades: Amgen, Marriot And Mastercard
November 01, 2021
On CNBC’s “Halftime Report Final Trades,” Car...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021
November 19, 2021
Upgrades Morgan Stanley upgraded the previous rating for EQT Corp (NYSE:
Via
Benzinga
3 Nasdaq Stocks to Buy and Hold for Years
November 10, 2021
Many companies are showing strong continued growth, but investors should focus on stocks to buy with the best long-term prospects.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
Making a Difference When You Invest? Medexus Says It Improves Lives
November 10, 2021
Photo by Hernan Pauccara from Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...
Via
Benzinga
This Company Says Its New Topical Therapy Trials Bringing Hope to People Exposed to Biofilm Bacteria
November 09, 2021
Photo by Louis Reed on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner...
Via
Benzinga
How Are Biotech ETFs Reacting To These Q3 Earnings Releases?
November 06, 2021
There's no denying that the pandemic has opened up investment opportunities in the biotech sector by triggering a race to introduce vaccines. Let’s take a look at big biotech earnings releases to see...
Via
Talk Markets
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...
Via
Benzinga
Amgen Q3 Earnings Saved By Higher Volumes Despite Pricing Pressure On Some Drugs
November 03, 2021
Amgen Inc's (NASDAQ: AMGN) Q3 revenues increased 4% to $6.71 billion, slightly beating the consensus of $6.68 billion. The increase is driven by higher unit demand...
Via
Benzinga
A Peek Into The Markets: US Stock Futures Mixed; All Eyes On Fed Decision
November 03, 2021
Pre-open movers U.S. stock futures traded mixed in early pre-market trade after settling at another record highs in the previous session. The Federal Reserve will announce its...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
5 Stocks To Watch For November 3, 2021
November 03, 2021
Some of the stocks that may grab investor focus today are: Wall Street expects CVS Health Corp (NYSE: CVS) to report quarterly earnings at $1.77 per share on revenue of $70.49...
Via
Benzinga
Amgen Inc. (AMGN) Q3 2021 Earnings Call Transcript
November 03, 2021
AMGN earnings call for the period ending October 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Amgen: Q3 Earnings Insights
November 02, 2021
Amgen (NASDAQ:AMGN) reported its Q3 earnings results on Tuesday, November 2, 2021 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Amgen their...
Via
Benzinga
Amgen Dips Despite Third-Quarter Beat With Sales Guidance Just In Line
November 02, 2021
Amgen stock fell late Tuesday after the company beat third-quarter forecasts, but 2021 sales guidance was just in line with estimates.
Via
Investor's Business Daily
Healthcare Stocks Subject to Government Policy
November 02, 2021
The market this morning isn’t moving much, but today’s tepid start is coming on the heels of yesterday’s record closes on the Dow, the S&P 500, and the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
November 02, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus SAB Spikes On Analyst Action SAB Biotherapeutics, Inc. (NASDAQ: SABS) shares...
Via
Benzinga
Exposures
COVID-19
Mirati Therapeutics COO, CMO Exit, Completing Management Overhaul
November 01, 2021
Shares of Mirati Therapeutics, Inc. (NASDAQ: MRTX) are retreating sharply Monday following two executive departures. What Happened: Mirati, a clinical-stage targeted oncology...
Via
Benzinga
Amgen's Earnings Outlook
November 01, 2021
Amgen (NASDAQ:AMGN) is set to give its latest quarterly earnings report on Tuesday, 2021-11-02. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
Carter Worth Says This Stock Is 'So Bad That It Is Good'
November 01, 2021
On CNBC's "Options Action," Carter Worth...
Via
Benzinga
< Previous
1
2
...
31
32
33
34
35
36
37
38
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.